IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2387
-0.0092 (-3.71%)
Oct 28, 2026, 4:00 PM EDT - Market closed
IGC Pharma Market Cap
IGC Pharma has a market cap or net worth of $24.68 million as of October 28, 2026. It is the 35,293rd most valuable company in the world and the 5,082nd biggest in the United States. Its market cap has decreased by 35.06% in one year.
Market Cap
24.68M
Enterprise Value
23.69M
1-Year Change
-35.06%
Global Rank
Country Rank
#5,082 United States
Category
ChartMarket Cap Chart
Since May 24, 2006, IGC Pharma's market cap has decreased from $69.50M to $24.68M, a decrease of -64.49%. That is a compound annual growth rate of -4.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 24.68M | -5.09% |
| Dec 31, 2025 | 26.00M | - |
| Dec 31, 2024 | 26.00M | 46.07% |
| Dec 29, 2023 | 17.80M | 5.33% |
| Dec 30, 2022 | 16.90M | -66.13% |
| Dec 31, 2021 | 49.90M | -22.52% |
| Dec 31, 2020 | 64.40M | 158.63% |
| Dec 31, 2019 | 24.90M | -72.49% |
| Dec 31, 2018 | 90.50M | 222.06% |
| Dec 29, 2017 | 28.10M | 255.70% |
| Dec 30, 2016 | 7.90M | 102.56% |
| Dec 31, 2015 | 3.90M | -58.06% |
| Dec 31, 2014 | 9.30M | 19.23% |
| Dec 31, 2013 | 7.80M | -3.70% |
| Dec 31, 2012 | 8.10M | 32.79% |
| Dec 30, 2011 | 6.10M | -22.78% |
| Dec 31, 2010 | 7.90M | -53.80% |
| Dec 31, 2009 | 17.10M | 101.18% |
| Dec 31, 2008 | 8.50M | -89.66% |
| Dec 31, 2007 | 82.20M | 0.74% |
| Dec 29, 2006 | 81.60M | 17.41% |
| May 24, 2006 | 69.50M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 30.42M |
| TransCode Therapeutics | 29.97M |
| Aligos Therapeutics | 29.85M |
| BriaCell Therapeutics | 29.79M |
| BioStem Technologies | 29.18M |
| CEL-SCI | 28.85M |
| ABVC BioPharma | 27.00M |
| Atossa Therapeutics | 25.95M |